Yantai Zhenghai Bio-Tech Co., Ltd. (300653) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Yantai Zhenghai Bio-Tech Co., Ltd.

Why is Yantai Zhenghai Bio-Tech Co., Ltd. ?

Poor long term growth as Net Sales has grown by an annual rate of -0.16% and Operating profit at -16.58% over the last 5 years

The company has declared Negative results for the last 10 consecutive quarters

OPERATING CASH FLOW(Y) Lowest at CNY 84.93 MM
ROCE(HY) Lowest at 7.75%
NET SALES(Q) Lowest at CNY 81.03 MM

With ROE of 7.34%, it has a expensive valuation with a 2.94 Price to Book Value

Over the past year, while the stock has generated a return of -21.59%, its profits have fallen by -43.2%
At the current price, the company has a high dividend yield of 1.9

Consistent Underperformance against the benchmark over the last 3 years

Along with generating -21.59% returns in the last 1 year, the stock has also underperformed China Shanghai Composite in each of the last 3 annual periods

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Yantai Zhenghai Bio-Tech Co., Ltd. for you?

Medium Risk, Low Return

Absolute

Risk Adjusted

Volatility

Yantai Zhenghai Bio-Tech Co., Ltd.

-25.56%

-1.00

30.44%

China Shanghai Composite

19.22%

1.46

13.80%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-0.16%

EBIT Growth (5y)

-16.58%

EBIT to Interest (avg)

100.00

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.72

Sales to Capital Employed (avg)

0.41

Tax Ratio

10.86%

Dividend Payout Ratio

60.36%

Pledged Shares

Institutional Holding

ROCE (avg)

62.58%

ROE (avg)

17.86%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

2.94

EV to EBIT

34.18

EV to EBITDA

26.47

EV to Capital Employed

7.78

EV to Sales

5.78

PEG Ratio

Dividend Yield

1.90%

ROCE (Latest)

22.78%

ROE (Latest)

7.34%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bullish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Dow Theory

Mildly Bullish

Bearish

OBV

Mildly Bullish

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

1What is working for the Company

RAW MATERIAL COST(Y)

Fallen by -6.73% (YoY

-17What is not working for the Company

OPERATING CASH FLOW(Y)

Lowest at CNY 84.93 MM

ROCE(HY)

Lowest at 7.75%

NET SALES(Q)

Lowest at CNY 81.03 MM

OPERATING PROFIT(Q)

Lowest at CNY 13.81 MM

OPERATING PROFIT MARGIN(Q)

Lowest at 17.05 %

PRE-TAX PROFIT(Q)

Lowest at CNY 14.51 MM

NET PROFIT(Q)

Lowest at CNY 12.44 MM

EPS(Q)

Lowest at CNY 0.08

Here's what is working for Yantai Zhenghai Bio-Tech Co., Ltd.

Raw Material Cost

Fallen by -6.73% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Yantai Zhenghai Bio-Tech Co., Ltd.

Operating Cash Flow

Lowest at CNY 84.93 MM and Fallen

In each year in the last three years

MOJO Watch

The company's cash revenues from business operations are falling

Operating Cash Flows (CNY MM)

Net Sales

Lowest at CNY 81.03 MM

in the last five periods

MOJO Watch

Near term sales trend is negative

Net Sales (CNY MM)

Net Sales

At CNY 81.03 MM has Fallen at -10.82%

over average net sales of the previous four periods of CNY 90.86 MM

MOJO Watch

Near term sales trend is negative

Net Sales (CNY MM)

Operating Profit

Lowest at CNY 13.81 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is negative

Operating Profit (CNY MM)

Operating Profit Margin

Lowest at 17.05 %

in the last five periods

MOJO Watch

Company's profit margin has deteriorated

Operating Profit to Sales

Pre-Tax Profit

Lowest at CNY 14.51 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (CNY MM)

Pre-Tax Profit

At CNY 14.51 MM has Fallen at -30.09%

over average net sales of the previous four periods of CNY 20.75 MM

MOJO Watch

Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (CNY MM)

Net Profit

Lowest at CNY 12.44 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is negative

Net Profit (CNY MM)

Net Profit

At CNY 12.44 MM has Fallen at -36.01%

over average net sales of the previous four periods of CNY 19.44 MM

MOJO Watch

Near term Net Profit trend is negative

Net Profit (CNY MM)

EPS

Lowest at CNY 0.08

in the last five periods

MOJO Watch

Declining profitability; company has created lower earnings for shareholders

EPS (CNY)